aldosterone has been researched along with Liver Steatosis in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperaldosteronism has been reported to be associated with a higher prevalence of non-alcoholic fatty liver disease (NAFLD)." | 1.56 | The risk factors for hepatic steatosis in patients with primary aldosteronism. ( Atsumi, T; Baba, S; Nakamura, A; Obara, S; Sakai, H; Shibayama, Y; Terae, S; Usubuchi, H; Wada, N, 2020) |
| "Although nonalcoholic fatty liver disease (NAFLD) is considered a cardiometabolic risk factor, no data exist on its prevalence and clinical relevance in AI." | 1.38 | Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma. ( Alexandraki, K; Apostolopoulou, G; Chrousos, G; Kaltsas, G; Markou, A; Papanastasiou, L; Pappa, T; Piaditis, G; Samara, C; Tsiavos, V, 2012) |
| "Insulin resistance is associated with nonalcoholic fatty liver disease (NAFLD) and may play a role in its pathophysiology." | 1.36 | Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study. ( Bertello, C; Catena, C; Dalla Pozza, A; Ermani, M; Fabris, B; Fallo, F; Mulatero, P; Sabato, N; Sechi, LA; Sonino, N; Tecchio, M; Tona, F, 2010) |
| "Although non-alcoholic steatohepatitis (NASH) may progress to cirrhosis and hepatocellular carcinoma (HCC), no effective therapeutic modalities have been fully established yet." | 1.36 | Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats. ( Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Namisaki, T; Noguchi, R; Shirai, Y; Tsujimoto, T; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Shibayama, Y | 1 |
| Wada, N | 1 |
| Baba, S | 1 |
| Obara, S | 1 |
| Sakai, H | 1 |
| Usubuchi, H | 1 |
| Terae, S | 1 |
| Nakamura, A | 1 |
| Atsumi, T | 1 |
| Gamliel-Lazarovich, A | 1 |
| Raz-Pasteur, A | 1 |
| Coleman, R | 1 |
| Keidar, S | 1 |
| Fallo, F | 1 |
| Dalla Pozza, A | 1 |
| Tecchio, M | 1 |
| Tona, F | 1 |
| Sonino, N | 1 |
| Ermani, M | 1 |
| Catena, C | 1 |
| Bertello, C | 1 |
| Mulatero, P | 1 |
| Sabato, N | 1 |
| Fabris, B | 1 |
| Sechi, LA | 1 |
| Noguchi, R | 1 |
| Yoshiji, H | 1 |
| Ikenaka, Y | 1 |
| Kaji, K | 1 |
| Shirai, Y | 1 |
| Aihara, Y | 1 |
| Yamazaki, M | 1 |
| Namisaki, T | 1 |
| Kitade, M | 1 |
| Yoshii, J | 1 |
| Yanase, K | 1 |
| Kawaratani, H | 1 |
| Tsujimoto, T | 1 |
| Fukui, H | 1 |
| Papanastasiou, L | 1 |
| Pappa, T | 1 |
| Samara, C | 1 |
| Apostolopoulou, G | 1 |
| Tsiavos, V | 1 |
| Markou, A | 1 |
| Alexandraki, K | 1 |
| Piaditis, G | 1 |
| Chrousos, G | 1 |
| Kaltsas, G | 1 |
| Berkowitz, HD | 1 |
| Mullen, JL | 1 |
| Miller, LD | 1 |
| Rosato, EF | 1 |
| Wexler, BC | 1 |
| Judd, JT | 1 |
| Lutmer, RF | 1 |
| Saroff, J | 1 |
7 other studies available for aldosterone and Liver Steatosis
| Article | Year |
|---|---|
The risk factors for hepatic steatosis in patients with primary aldosteronism.
Topics: Adult; Aldosterone; Blood Pressure; Fatty Liver; Female; Humans; Hyperaldosteronism; Hypertension; I | 2020 |
The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker.
Topics: Adrenalectomy; Aldosterone; Animals; Blood Glucose; Blood Pressure; Cells, Cultured; Cholesterol; Di | 2013 |
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study.
Topics: Adult; Aldosterone; Fatty Liver; Female; Homeostasis; Humans; Hyperaldosteronism; Hypertension; Hypo | 2010 |
Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats.
Topics: Aldosterone; Animals; Disease Progression; Fatty Liver; Liver Cirrhosis; Liver Neoplasms; Male; Rats | 2010 |
Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma.
Topics: Adrenal Gland Neoplasms; Aldosterone; Anthropometry; Body Mass Index; Case-Control Studies; Fatty Li | 2012 |
Improved renal function and inhibition of renin and aldosterone secretion following peritoneovenous (LeVeen) shunt.
Topics: Aldosterone; Angiotensinogen; Ascites; Creatinine; Diuresis; Fatty Liver; Glomerular Filtration Rate | 1978 |
Metabolic and histopathological consequences of a fatty liver during the acute stages of myocardial infarction in rats.
Topics: Acute Disease; Adrenal Glands; Alanine Transaminase; Aldosterone; Animals; Aspartate Aminotransferas | 1971 |